Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pipeline of anti‐Mycobacterium abscessussmall molecules: Repurposable drugs and promising novel chemical entities

1 Mar 2021

Abstract excerpt

The Mycobacterium abscessus complex is a group of emerging pathogens that are difficult to treat. There are no effective drugs for successful M. abscessus pulmonary infection therapy, and existing drug regimens recommended by the British or the American Thoracic Societies are associated with poor clinical outcomes. Therefore, novel antibacterial drugs are urgently needed to contain this global threat. The current...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Infectious Diseases and Mycology
Share to Mycobacterium research and diagnosis
Share to Tuberculosis Research and Epidemiology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33645845
DOI: 10.1002/med.21798

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pipeline of anti‐Mycobacterium abscessussmall molecules: Repurposable drugs and promising novel chemical entitiesPMID 33645845Read ↗

Pathogen Box screening for hit identification against Mycobacterium abscessusSemantic proximity Read ↗

The novel drug candidate VOMG kills Mycobacterium abscessus and other pathogens by inhibiting cell divisionSemantic proximity Read ↗

Piperidine-4-Carboxamides Target DNA Gyrase in Mycobacterium abscessusSemantic proximity Read ↗

Structural-guided fragment-based drug discovery applied to antitoxin, MAB3862 opens a new possibility of exploring the Toxin and Antitoxin for antibioticsSemantic proximity Read ↗

Resistance to Thiacetazone Derivatives Active against Mycobacterium abscessus Involves Mutations in the MmpL5 Transcriptional Repressor MAB_4384.Semantic proximity Read ↗

Epetraborole Is Active against Mycobacterium abscessusSemantic proximity Read ↗

New structural classes of antituberculosis agentsSemantic proximity Read ↗

Rifabutin Is Active against Mycobacterium abscessus ComplexSemantic proximity Read ↗

Pharmacological validation of dihydrofolate reductase as a drug target in Mycobacterium abscessusSemantic proximity Read ↗

Activity of LCB01-0371, a Novel Oxazolidinone, against Mycobacterium abscessusSemantic proximity Read ↗

Active Benzimidazole Derivatives Targeting the MmpL3 Transporter in Mycobacterium abscessus.Semantic proximity Read ↗

Antitubercular 2-Pyrazolylpyrimidinones: Structure-Activity Relationship and Mode-of-Action Studies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.